CAU
ALAB icon

Caxton Associates (UK)’s Astera Labs ALAB Stock Holding History

Caxton Associates (UK)’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,480
Closed -$246K – 1039
2025
Q4 		$246K Buy
+1,480
New +$248K ﹤0.01% 664
2025
Q3 		– Sell
-163,753
Closed -$14.8M – 965
2025
Q2 		$14.8M Buy
+163,753
New +$12.9M 0.38% 36

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Caxton Associates (UK)'s ALAB Position: Q1 2026 in Review

Caxton Associates (UK) sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 1,480 shares — an estimated $246K sold.

Caxton Associates (UK) first reported a position in ALAB in Q2 2025 and held it in 2 quarters. The position peaked at $14.8M in Q2 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Caxton Associates (UK) reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
  • Caxton Associates (UK) sold 1,480 Astera Labs shares in Q1 2026, an estimated $246K.
  • Caxton Associates (UK) first reported a position in Astera Labs in Q2 2025 and held it in 2 quarters.
  • Caxton Associates (UK)'s Astera Labs position peaked at $14.8M in Q2 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.